• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1979 - 2002年法国慢性阻塞性肺疾病死亡情况:多病因分析

Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis.

作者信息

Fuhrman C, Jougla E, Nicolau J, Eilstein D, Delmas M-C

机构信息

Institut de Veille Sanitaire, 12 rue du Val d'Osne, 94415 Saint-Maurice Cedex, France.

出版信息

Thorax. 2006 Nov;61(11):930-4. doi: 10.1136/thx.2006.061267. Epub 2006 May 31.

DOI:10.1136/thx.2006.061267
PMID:16738039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2121171/
Abstract

BACKGROUND

A study was undertaken of deaths with an underlying or associated cause of chronic obstructive pulmonary disease (COPD), and trends in COPD mortality from 1979 to 2002 in France were analysed.

METHODS

Data were obtained from the Centre of Epidemiology on the Medical Causes of Death (CépiDc) for individuals aged 45 years and over. Owing to implementation of ICD-10 in 2000 for recording causes of death, two separate periods were analysed (1979-99 and 2000-2).

RESULTS

In 2000-2, COPD was the underlying cause of 1.4% of deaths (deaths from COPD) and was mentioned on the death certificate in 3.0% (deaths with COPD). The other main underlying causes in these cases were cardiovascular diseases (32.0%) and cancers (24.5%). In 1979-99, age standardised rates of death with COPD remained stable in men (-0.01%/year) and increased in women (+1.7%/year). The mean annual rates of death with COPD per 100 000 were 84 for men and 19 for women in 2000-2.

CONCLUSION

Multiple cause analysis improved the estimate of COPD related mortality. In 1979-99, COPD related mortality rates in France were stable in men but increased in women. Implementation of ICD-10 in 2000 introduced substantial discontinuities in mortality trends.

摘要

背景

开展了一项关于以慢性阻塞性肺疾病(COPD)为潜在或相关死因的死亡情况研究,并分析了1979年至2002年法国COPD死亡率的趋势。

方法

从死亡医学原因流行病学中心(CépiDc)获取45岁及以上个体的数据。由于2000年开始实施国际疾病分类第十版(ICD - 10)用于记录死因,因此分析了两个不同时期(1979 - 1999年和2000 - 2002年)。

结果

在2000 - 2002年期间,COPD是1.4%的死亡(COPD导致的死亡)的潜在原因,并且在死亡证明上被提及的占3.0%(伴有COPD的死亡)。这些病例中的其他主要潜在死因是心血管疾病(32.0%)和癌症(24.5%)。在1979 - 1999年期间,伴有COPD的年龄标准化死亡率在男性中保持稳定(每年 - 0.01%),而在女性中有所上升(每年 + 1.7%)。在2000 - 2002年期间,每10万人中伴有COPD的年平均死亡率男性为84,女性为19。

结论

多病因分析改进了COPD相关死亡率的估计。在1979 - 1999年期间,法国男性的COPD相关死亡率保持稳定,而女性有所上升。2000年实施ICD - 10导致死亡率趋势出现大幅间断。

相似文献

1
Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis.1979 - 2002年法国慢性阻塞性肺疾病死亡情况:多病因分析
Thorax. 2006 Nov;61(11):930-4. doi: 10.1136/thx.2006.061267. Epub 2006 May 31.
2
[Epidemiology of chronic obstructive pulmonary disease in France].[法国慢性阻塞性肺疾病的流行病学]
Rev Mal Respir. 2010 Feb;27(2):160-8. doi: 10.1016/j.rmr.2009.08.003. Epub 2010 Jan 19.
3
Death rates for asthma in English populations 1979-2007: comparison of underlying cause and all certified causes.1979-2007 年英国人群哮喘死亡率:根本死因与所有认证死因的比较。
Public Health. 2012 May;126(5):386-93. doi: 10.1016/j.puhe.2012.01.022. Epub 2012 Apr 18.
4
The concurrent COPD mortality doubles the mortality estimate from COPD as underlying cause in Lazio, Italy.在意大利拉齐奥地区,慢性阻塞性肺疾病(COPD)并发死亡率使将COPD作为潜在病因的死亡率估计值增加了一倍。
Respir Med. 2007 Sep;101(9):1988-93. doi: 10.1016/j.rmed.2007.04.004. Epub 2007 Jul 13.
5
Potential misclassification of causes of death from COPD.慢性阻塞性肺疾病(COPD)死亡原因的潜在错误分类。
Eur Respir J. 2006 Oct;28(4):781-5. doi: 10.1183/09031936.06.00152205. Epub 2006 Jun 28.
6
[An 18-year follow-up study on the risk factors of deaths regarding chronic obstructive pulmonary disease in Xi'an, China].[中国西安慢性阻塞性肺疾病死亡危险因素的18年随访研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Sep;27(9):765-8.
7
Mortality from chronic obstructive pulmonary disease among adults aged 25 years or older in North Carolina.北卡罗来纳州25岁及以上成年人中慢性阻塞性肺疾病的死亡率。
South Med J. 2011 Jan;104(1):20-3. doi: 10.1097/SMJ.0b013e3181fcda00.
8
Deaths with asthma in France, 2000-2005: a multiple-cause analysis.2000 - 2005年法国哮喘相关死亡情况:多病因分析
J Asthma. 2009 May;46(4):402-6. doi: 10.1080/02770900902795553.
9
Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis.1994-2010 年欧洲慢性阻塞性肺疾病死亡率趋势:一个联合回归分析。
Lancet Respir Med. 2014 Jan;2(1):54-62. doi: 10.1016/S2213-2600(13)70232-7. Epub 2013 Dec 6.
10
Trends in COPD mortality and hospitalizations in countries and regions of Asia-Pacific.亚太地区各国和各地区慢性阻塞性肺疾病(COPD)死亡率及住院率的趋势。
Respirology. 2009 Jan;14(1):90-7. doi: 10.1111/j.1440-1843.2008.01415.x.

引用本文的文献

1
All-cause and cause-specific mortality in individuals with COPD in China: a 16-year follow-up cohort study.中国慢性阻塞性肺疾病患者的全因死亡率和特定病因死亡率:一项16年随访队列研究。
Eur J Epidemiol. 2025 Jun 4. doi: 10.1007/s10654-025-01252-7.
2
Mortality Related to Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic: An Analysis of Multiple Causes of Death through Different Epidemic Waves in Veneto, Italy.COVID-19 大流行期间与慢性阻塞性肺疾病相关的死亡率:意大利威尼托地区通过不同流行波分析多种死亡原因。
Int J Environ Res Public Health. 2022 Oct 7;19(19):12844. doi: 10.3390/ijerph191912844.
3
Effects of LAMA/LABA Alone and in Combination on Cardiac Safety.长效抗胆碱能药物/长效β2受体激动剂单用及联用对心脏安全性的影响。
Int J Chron Obstruct Pulmon Dis. 2020 Aug 10;15:1931-1933. doi: 10.2147/COPD.S246356. eCollection 2020.
4
Quantifying cause-related mortality in Australia, incorporating multiple causes: observed patterns, trends and practical considerations.量化澳大利亚的与病因相关的死亡率,纳入多种病因:观察到的模式、趋势和实际考虑。
Int J Epidemiol. 2023 Feb 8;52(1):284-294. doi: 10.1093/ije/dyac167.
5
The effect of tiotropium/olodaterol versus fluticasone propionate/salmeterol on left ventricular filling and lung hyperinflation in patients with COPD.噻托溴铵/奥达特罗与丙酸氟替卡松/沙美特罗对 COPD 患者左心室充盈和肺过度充气的影响。
BMJ Open Respir Res. 2020 Dec;7(1). doi: 10.1136/bmjresp-2020-000741.
6
No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD.通过动态心电图分析比较噻托溴铵/奥达特罗与单一组分长期治疗对中重度至极重度慢性阻塞性肺疾病(COPD)患者心律失常或心率的影响
Int J Chron Obstruct Pulmon Dis. 2020 Aug 10;15:1945-1953. doi: 10.2147/COPD.S246350. eCollection 2020.
7
Absence of Adverse Effects of Tiotropium/Olodaterol Compared with the Monocomponents on Long-Term Heart Rate and Blood Pressure in Patients with Moderate-to-Very-Severe COPD.噻托溴铵/奥达特罗与单一组分相比对中重度至极重度 COPD 患者长期心率和血压的无不良影响。
Int J Chron Obstruct Pulmon Dis. 2020 Aug 10;15:1935-1944. doi: 10.2147/COPD.S246348. eCollection 2020.
8
Comparison of Serum Adiponectin in Smoke-induced Pulmonary Emphysema Rats Fed Different Diets.不同饮食喂养的烟雾诱导型肺气肿大鼠血清脂联素的比较
Chin Med J (Engl). 2016 Jan 20;129(2):187-93. doi: 10.4103/0366-6999.173486.
9
Decellularization and cell seeding of whole liver biologic scaffolds composed of extracellular matrix.由细胞外基质组成的全肝生物支架的去细胞化和细胞接种
J Clin Exp Hepatol. 2015 Mar;5(1):69-80. doi: 10.1016/j.jceh.2014.03.043. Epub 2014 Mar 28.
10
Mapping the cause-specific premature mortality reveals large between-districts disparity in Belgium, 2003-2009.绘制特定病因的过早死亡率显示,2003年至2009年期间比利时各地区之间存在巨大差异。
Arch Public Health. 2015 Mar 23;73(1):13. doi: 10.1186/s13690-015-0060-5. eCollection 2015.

本文引用的文献

1
Trends in the leading causes of death in the United States, 1970-2002.1970 - 2002年美国主要死因的趋势
JAMA. 2005 Sep 14;294(10):1255-9. doi: 10.1001/jama.294.10.1255.
2
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature.肺功能降低与心血管疾病死亡率之间的关系:一项基于人群的研究及对文献的系统综述
Chest. 2005 Jun;127(6):1952-9. doi: 10.1378/chest.127.6.1952.
3
Factors associated with reporting multiple causes of death.与报告多种死因相关的因素。
BMC Med Res Methodol. 2005 Jan 17;5(1):4. doi: 10.1186/1471-2288-5-4.
4
Mortality rates for common respiratory diseases in an English population 1979-1998: artefact and substantive trends.1979 - 1998年英国人群常见呼吸道疾病的死亡率:人为因素与实质趋势
J Public Health (Oxf). 2004 Mar;26(1):8-12. doi: 10.1093/pubmed/fdh099.
5
An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages.一项根据慢性阻塞性肺疾病全球倡议(GOLD)阶段对年轻成年人慢性阻塞性肺疾病进行的国际调查。
Thorax. 2004 Feb;59(2):120-5. doi: 10.1136/thorax.2003.011163.
6
What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis.慢性阻塞性肺疾病患者死因是什么?一项多病因编码分析。
Eur Respir J. 2003 Nov;22(5):809-14. doi: 10.1183/09031936.03.00031403.
7
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study.美国的肺功能与死亡率:来自第一次全国健康和营养检查调查随访研究的数据
Thorax. 2003 May;58(5):388-93. doi: 10.1136/thorax.58.5.388.
8
Characteristics of adults dying with COPD.慢性阻塞性肺疾病(COPD)终末期成人患者的特征。
Chest. 2002 Dec;122(6):2003-8. doi: 10.1378/chest.122.6.2003.
9
Chronic bronchitis among French adults: high prevalence and underdiagnosis.法国成年人中的慢性支气管炎:高患病率与诊断不足
Eur Respir J. 2002 Oct;20(4):806-12. doi: 10.1183/09031936.02.00042002.
10
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.1971 - 2000年美国慢性阻塞性肺疾病监测
MMWR Surveill Summ. 2002 Aug 2;51(6):1-16.